Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Advanced Proteome Therapeutics in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Advanced Proteome Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | -0.660% | -0.658% | -21.354% | 77.647% | -9.036% | -9.036% | -71.509% |
| Northwest Biotherapeutics Inc. | 0.000% | -2.500% | 18.902% | -18.067% | -5.340% | -63.551% | -84.016% |
| Celldex Therapeutics | -0.350% | -5.499% | -10.640% | 49.138% | 17.955% | -13.500% | 16.159% |
News
Booz Allen Hamilton Q4 Earnings Call Highlights
Key Points
- Interested in Booz Allen Hamilton Holding Corporation? Here are five stocks we like better.
- Revenue fell in fiscal 2026, but profitability beat expectations. Booz Allen reported
Is Alphabet Moving in on Nvidia's Territory?
Nvidia (NASDAQ: NVDA) has long been the "go-to" source for the top-performing artificial intelligence (AI) chips. The company's graphics processing units (GPUs) fuel unavoidable AI tasks, like the
Is It Too Late to Buy Cerebras Systems After the Stock Soared Following Its IPO?
The biggest driving force in the stock market over the past few years has been artificial intelligence (AI) infrastructure, so when AI chip company Cerebras Systems (NASDAQ: CBRS) made its public


